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disease can be managed in a way that allows 
some patients to live productive lives. 
Ischemia leads  
to infiltration  
of the kidney by T cells
Transplantation often includes a period of 
ischemia before the organ is harvested and 
anastomosed to the recipient’s blood supply. 
Ischemia is increasingly recognized as being 
accompanied by inflammation. As they 
report in this issue, Ascon et al. induced 
ischemia in mice and studied their kidneys 
after reperfusion. The authors focused on 
the invasion of immune cells; they iso-
lated various cell types from the mouse 
kidneys and analyzed them using FACS. 
Two weeks after ischemia, they found an 
abundance of CD8+ T cells. Further, for 
long periods after the ischemic injury, the 
kidneys harbored CD8+ as well as CD4+ 
cells. Many of these cells expressed markers 
of activation and effector memory. Signifi-
cant induction of inflammatory cytokines 
such as interleukin-1β, interleukin-6, 
interferon-γ, and others also occurred. 
When the animals were depleted of T cells 
(CD8+ and CD4+) before the induction of 
the ischemia, they had significant protec-
tion from renal injury as well as a reduction 
in cytokine expression. The fact that T-cell 
depletion prevents some of these changes 
suggests that the infiltration of T cells is pri-
mary and that overexpression of cytokines 
is secondary. However, it is also likely that 
ischemia could induce the expression of a 
World Kidney Day
The impact of chronic kidney disease (CKD) 
on worldwide health cannot be overem-
phasized. Previously, many physicians and 
scientists believed that CKD was a problem 
unique to the industrialized world. However, 
an avalanche of papers has documented the 
global burden of CKD. Three years ago, this 
information led the International Society of 
Nephrology and the International Federa-
tion of Kidney Foundations to launch World 
Kidney Day, a public education campaign 
to increase awareness and prevention of 
CKD. The campaign has resulted in remark-
able efforts in many areas of the world. Led 
by nephrologists, nurses, technicians, and 
patients, these efforts include involvement 
by a wide variety of people in the fight 
against CKD. You can check http://www.
worldkidneyday.org to find events in your 
area. Participate in any one or more of these 
activities, whether it be screening for hyper-
tension and proteinuria, passing out fliers, 
or bringing up the subject with friends and 
family. The larger goal is to get legislators, 
government officials, and political leaders 
to help in this endeavor. Despite the impact 
of CKD, doctors now have the tools to limit 
its damage by preventing or slowing its pro-
gression. Further, unlike many diseases of 
the heart or lungs or brain, end-stage renal 
chemotactic factor, which would encourage 
T cells to infiltrate the kidney. See page 526.
Quality of life in 
nocturnal dialysis
Discussion has increased regarding the meth-
ods of dialysis; specifically, the newly described 
system of nocturnal dialysis has attracted a 
significant amount of attention. The tech-
nique provides longer periods of dialysis and 
appears to be better suited to the lifestyle of 
an active patient. Whether it improves the 
outcome of dialysis remains an active area of 
investigation. Manns et al. now examine the 
question of whether it improves the percep-
tion of well-being for patients on dialysis. In 
this well-designed study, the authors admin-
istered standardized questions that estimate 
the impact of dialysis on quality of life. They 
divided the questions into general ones and 
those specific to patients with different kinds 
of kidney disease. A comparison between 
patients before dialysis and those after two 
types of dialysis showed that nocturnal dialy-
sis had no effect on quality of life. However, 
nocturnal dialysis was shown to have a statis-
tically significant effect on patients with end-
stage renal disease. See page 542.
IRI, ischemia–reperfusion injury.
It’s now cheaper to print color figures in KI
Have you been concerned in the past about the cost of print-
ing color figures in Kidney International (KI)? KI has listened 
to your concerns and is now offering permanently reduced 
pricing for color figures—a flat fee of $500 per printed page, 
no matter how many color figures are on a page. This pricing 
is more affordable for authors and competitive with other top 
scientific journals. We want to make it easier for authors to 
publish the color figures that demonstrate important scien-
tific findings, and our new pricing reflects our commitment to 
achieving this goal.
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